@FierceMedDev: Device tax at center of government funding battle. Article | Follow @FierceMedDev
@MarkHFierce: KKR made it official, grabbing an 80% stake of Panasonic's healthcare arm for $1.67B - much higher than predicted. ICYMI Friday | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Medtronic lands U.S. approval of early-generation artificial pancreas. Story from FierceDrugDelivery | Follow @MichaelGFierce
> If a government shutdown comes as expected on Oct. 1, the FDA will lose 6,620 employees, about 45% of its staff. The agency would also have to cease many inspections, enforcement actions and monitoring operations. Story
> Covidien ($COV), which has announced plans for layoffs and plant closings, will report its fourth-quarter results on Nov. 8, 2013. Item
> Micell Technologies said that the American College of Cardiology's Cardiovascular Interventions Journal will publish a peer-reviewed article discussing results from the DESSOLVE I trial of its new drug-eluting absorbable polymer coronary stent system. Item
> Critical Diagnostics is touting the results of a new study that showed ST2 is a better biomarker than Galectin-3 to help diagnose and treat heart failure patients. (The company produces an ST2 assay.) Item
> Canada's Amulyte wants to raise $2 million through crowdfunding to help develop an emergency alert device for senior citizens. Story
Biotech News
@FierceBiotech: AstraZeneca CEO celebrates 1st anniversary with promising lung cancer data. More | Follow @FierceBiotech
@JohnCFierce: Pfizer nabs autoimmune disease drug rights for $25M upfront. News | Follow @JohnCFierce
@DamianFierce: Few are optimistic about a last-minute budget deal. Here's what happens at the FDA after a shutdown: Article | Follow @DamianFierce
> Lundbeck to cull 200 staffers in cost-cutting drive. Item
> Relypsa pitches $126M IPO as lead CKD drug nears moment of PhIII truth. Story
> Achillion shares crushed in a rout as hep C blockbuster hopes fade. Article
> Roche's new round of lung cancer data keeps spotlight on immunotherapies. More
Pharma News
@FiercePharma: Trending on our website (still): If pharma reps can't get in doctors' front doors, try alternate routes. Story | Follow @FiercePharma
@EricPFierce: U.K. tosses lean, but important bone to pharma with expected extension of cancer drug fund. ICYMI Friday | Follow @EricPFierce
@CarlyHFierce: Bristol-Myers melanoma drug Yervoy helps patients live years longer, study finds. Story | Follow @CarlyHFierce
> Germany's Bayer taps Pfizer's Olivier Brandicourt to head Bayer HealthCare. News
> Look out, pharma marketers. Obamacare will change your lives. More
> Roche CEO: 'Extremely' open to talk with Novartis about teaming up. Article
CRO News
> Quintiles jumps into personalized medicine for cancer trials. More
> Merged at last, PRA and RPS say they're fourth-largest CRO. Report
> InVentiv launches doc network for late-stage trials. Story
> JSS snaps up Latin American CRO. Article
> Parexel launches China-focused service as local demand heats up. News
Biotech IT News
> FDA taking hands-off approach to regulation of most apps. More
> Genohub talks up 'Kayak' for NGS services. Report
> NIH calls for comments on draft genomics data sharing policy. Story
> Business behind Google Earth for the human body raises $4M. Item
> Pfizer to give patients access to their trial data. Article